Document Detail


MicroRNAs in brain metastases: big things come in small packages.
MedLine Citation:
PMID:  23138927     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Metastatic brain tumors provide a formidable obstacle in the survival of affected cancer patients, an obstacle that current treatment is essentially ineffective against. Our understanding of the metastatic cascade has demonstrated the role of incorrectly regulated protein expression and proved it to be a crucial component of this process. Recently, molecular studies have emphasized the role of microRNAs, small non-coding RNAs that alter protein expression, in the regulation of both normal and abnormal biological processes, including cancer and its metastasis to the brain. Furthermore, studies have demonstrated the ability to distinguish normal from cancerous cells, primary from secondary brain tumors, and correctly categorize metastatic brain tumor tissue of origin based solely on microRNA profiles. Interestingly, manipulation of microRNAs has proven effective in cancer treatment. With the promise of reduced toxicity, increased efficacy, and individually directed therapy, using microRNA in the treatment of metastatic brain tumors may prove very useful. In this review, we focus on the multiple potential microRNA targets for the treatment of metastatic brain lesions as well as current and future directions for its use in gene therapy.
Authors:
Ryan McDermott; Patrik Gabikian; Purvaba Sarvaiya; Ilya Ulasov; Maciej S Lesniak
Related Documents :
3123087 - Elevation of glutathione transferase activity in human lung tumor.
10987267 - Increased expression of h/t-cadherin in tumor-penetrating blood vessels.
16361567 - Antitumor vascular strategy for controlling experimental metastatic spread of human sma...
22030137 - Matrix metalloproteinase-2 (mmp-2) and mmp-9 expression in invasive ductal carcinoma of...
19430887 - Decreased rate of infection in glioblastoma patients with allelic loss of chromosome 10q.
17373897 - Vascular endothelial growth factor and immunosuppression in cancer: current knowledge a...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-9
Journal Detail:
Title:  Journal of molecular medicine (Berlin, Germany)     Volume:  -     ISSN:  1432-1440     ISO Abbreviation:  J. Mol. Med.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9504370     Medline TA:  J Mol Med (Berl)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
The Brain Tumor Center, The University of Chicago, 5841 South Maryland Ave, M/C 3026, Chicago, IL, 60637, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The thalidomide disaster, lessons from the past.
Next Document:  Negative regulation of NEP expression by hypoxia.